Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Vitamin B Effects on Cognitive Performance Uncertain

By HospiMedica International staff writers
Posted on 26 Nov 2014
A new study suggests that vitamin B12 and folate supplements may not actually reduce the risk of memory and thinking problems.

Researchers at Wageningen University (The Netherlands) conducted a double-blind, randomized, placebo-controlled trial to investigate the effects of two-year folic acid and vitamin B12 supplementation on the cognitive performance of elderly people with elevated homocysteine (Hcy) levels, a potential modifiable dementia risk factor. More...
The study included 2,919 elderly participants (65 years and older), who received a daily tablet with 400 µg folic acid and 500 µg vitamin B12, or placebo; both tablets contained 15 µg vitamin D3. Global cognitive functioning was assessed by memory and thinking skills tests at the beginning and end of the study.

The results showed that while mean Hcy concentrations decreased by 5.0 µmol/L in the vitamin B12 group and 1.3 µmol/L in the placebo group, cognitive domain scores did not differ over time between the two groups. The researchers added that while it is possible that vitamin B12 and folate supplements could slightly slow the rate of decline of global cognition, the small difference may be attributable to chance alone. The study was published on November 12, 2014, in Neurology.

“Since homocysteine levels can be lowered with folic acid and vitamin B12 supplements, the hope has been that taking these vitamins could also reduce the risk of memory loss and Alzheimer's disease,” said lead author Rosalie Dhonukshe-Rutten, PhD. “although the homocysteine levels decreased by more in the group taking the B vitamins than in the group taking the placebo, unfortunately there was no difference between the two groups in the scores on the thinking and memory tests.”

A high level of homocysteine in the blood makes a person more prone to endothelial cell injury, which leads to inflammation in the blood vessels that could lead to ischemic injury. High Hcy is therefore a possible risk factor for coronary artery disease (CAD), thrombosis, neuropsychiatric illness, and fractures. Previous studies have also shown links between higher Hcy levels, memory loss, and Alzheimer's disease.

Related Links:
Wageningen University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.